State of Dis Union
Not logged in
KILLING SACRED COWS: Novartis director campaigns for Obama; Company gets sweet deal!
Submitted by jcbrook on Fri, 08/21/2009 - 2:44pm.
[Novartis] Media releases
February 26, 2008 16:46 CET
Ann Fudge elected to the Board of Directors...
That notice can be found here.
------------------------------------------
"...the Obama campaign has brought onboard Ann M. Fudge, former chair and CEO of global advertising giant Young & Rubicam Brands."
For full article dated August 28th, 2008, click here.
------------------------------------------
Novartis's board can be found here.
Ms. Fudge is a Trustee of the Rockefeller Foundation and Chair of the U.S.
Programs Advisory Panel of the Gates Foundation.
She's also on the board of directors of the Council on Foreign Relations.
That info can be found here.
------------------------------------------
January 15, 2009 16:00 CET
US Department of Health and Human Services awards Novartis USD 486 million contract to build manufacturing facility for pandemic flu vaccine
For full Novartis media release, click here.
Delicious
Digg
Facebook
Technorati
June 12, 2009 07:15 CET
Novartis successfully demonstrates capabilities of cell-based technology for production of A(H1N1) vaccine
"....More than 30 governments have made requests to Novartis to supply them with influenza A(H1N1) vaccine ingredients. These are a combination of pre-existing pandemic vaccine supply agreements and new requests for vaccines across all our production platforms including egg-based manufacturing. The US Department of Health and Human Service's $289 million order in May 2009[1] with Novartis was the largest of the US government's commitments to influenza A(H1N1) vaccine ingredients. That order included Novartis proprietary adjuvant MF59®, which can be added to influenza vaccines to help stimulate the human body's immune response to the vaccine...."
The entire news release can be read click here.
---------------------------------------------------------
The TimesOnline reported on June 11th, 2009, that the WHO had declared swine flu to be pandemic.
Basel, August 7, 2008 - Novartis announced today that it started shipments of its Fluvirin® Influenza Virus Vaccine to US health care facilities and practitioners for the 2008/2009 influenza season.
The company is producing up to 40 million doses of Fluvirin, with the World Health Organization recommended change in all three virus strains included in the influenza vaccine composition[1]. This year's influenza vaccine contains the following three strains of the influenza virus:
A/Brisbane/59/2007 (H1N1)-like virus (A/Brisbane/59/2007 IVR-148)
A/Brisbane/10/2007 (H3N2)-like virus (A/Uruguay/716/2007 NYMC X-175C)
B/Florida/4/2006-like virus (B/Florida/4/2006)
--------------------------------------------------------
The entire news release can be found here.